167 followers
PubMed_ A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation. https://t.co/GL5L8m9HJN
PubMed_ A significant response to a combination of trastuzumab and vinorelbine in HER2-negative metastatic breast cancer with HER2 V777L mutation. https://t.co/GL5L8m9HJN